Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,108 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00215345 | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer | unknown | Phase 2 | 66 | Department of Veterans Affairs, New JerseyFED | 1 | Sep 22, 2005 | clinicaltrials |
| NCT00218205 | A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer | unknown | Phase 2 | 28 | Department of Veterans Affairs, New JerseyFED | 1 | Sep 22, 2005 |
| clinicaltrials |
| NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 23 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00201318 | A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen | completed | Phase 2 | 50 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00188370 | Ultrasound Biomicroscopy - Apoptosis | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00175747 | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | completed | Phase 2 / Phase 3 | 120 | University of British ColumbiaOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00164437 | CD-ROM Intervention for Prostate Cancer Screening | completed | Phase 2 / Phase 3 | 554 | Centers for Disease Control and PreventionFED | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00154713 | Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | unknown | Phase 1 / Phase 2 | 37 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00155272 | Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 19 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00152087 | A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible. | unknown | Phase 2 | 25 | St. Joseph's Hospital, FloridaOTHER | 1 | Sep 9, 2005 | clinicaltrials |
| NCT00140374 | Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) | completed | Phase 1 / Phase 2 | 36 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140387 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) | completed | Phase 1 / Phase 2 | 20 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140400 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 50 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00139633 | Selective Dose Escalation for Esophageal Cancer | unknown | Phase 2 | 25 | The Oregon ClinicOTHER | 1 | Aug 31, 2005 | clinicaltrials |
| NCT00073385 | Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 225 | Titan PharmaceuticalsINDUSTRY | 3 | Aug 30, 2005 | clinicaltrials |
| NCT00083473 | A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia | terminated | Phase 2 | 28 | Titan PharmaceuticalsINDUSTRY | 1 | Aug 30, 2005 | clinicaltrials |
| NCT00087477 | A Pilot Study of Pivanex in Patients With Malignant Melanoma | terminated | Phase 1 / Phase 2 | 14 | Titan PharmaceuticalsINDUSTRY | 1 | Aug 30, 2005 | clinicaltrials |
| NCT00127595 | Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract | terminated | Phase 2 | 28 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 24, 2005 | clinicaltrials |
| NCT00126243 | Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma | terminated | Phase 2 | 60 | French National Agency for Research on AIDS and Viral HepatitisOTHER_GOV | 1 | Aug 17, 2005 | clinicaltrials |
| NCT00116155 | Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | — | Cell GenesysINDUSTRY | 0 | Jun 28, 2005 | clinicaltrials |
| NCT00002003 | Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas | completed | Phase 2 | — | Lederle LaboratoriesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002131 | A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 28 | Otsuka America PharmaceuticalINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002160 | A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain | completed | Phase 2 | 100 | NeurexINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002167 | Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. | completed | Phase 2 | 78 | Clinical SolutionsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002185 | A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 | completed | Phase 2 | 20 | Agouron PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002188 | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 27 | Anderson Clinical ResearchINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00002189 | Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals | completed | Phase 2 | — | Baker Norton PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002212 | A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 27 | Ligand PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002221 | Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 5 | RibozyomeINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002259 | Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma | completed | Phase 2 | — | Lederle LaboratoriesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002314 | A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 2 | — | Hoffmann-La RocheINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00005931 | SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment | completed | Phase 2 | 30 | SUGENINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006198 | Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006200 | Thalidomide and Dacarbazine for Metastatic Melanoma | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006332 | Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate | completed | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006433 | Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00013806 | CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022932 | Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP | unknown | Phase 2 | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022945 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma | completed | Phase 2 | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00028158 | Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer | completed | Phase 1 / Phase 2 | 65 | MediGeneINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer | terminated | Phase 2 / Phase 3 | 240 | FeRxINDUSTRY | 8 | Jun 24, 2005 | clinicaltrials |
| NCT00036426 | Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma | unknown | Phase 2 | 22 | FavrilleINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00042497 | Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma | suspended | Phase 2 | 60 | AnosysINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00043433 | Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. | unknown | Phase 2 | 35 | TularikINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00043459 | Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. | terminated | Phase 2 | 35 | TularikINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00048529 | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus | suspended | Phase 2 | 70 | TularikINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00054951 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads | unknown | Phase 1 / Phase 2 | 30 | FeRxINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00055562 | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma | completed | Phase 2 / Phase 3 | 274 | Celgene CorporationINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | terminated | Phase 2 / Phase 3 | 750 | TularikINDUSTRY | 11 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Sep 22, 2005source: clinicaltrials